nodes	percent_of_prediction	percent_of_DWPC	metapath
Enalapril—SLC22A7—Fluorouracil—pancreatic cancer	0.177	0.271	CbGbCtD
Enalapril—SLC22A7—Docetaxel—pancreatic cancer	0.135	0.207	CbGbCtD
Enalapril—ABCB1—Tamoxifen—pancreatic cancer	0.0456	0.0696	CbGbCtD
Enalapril—ABCB1—Gemcitabine—pancreatic cancer	0.0392	0.0599	CbGbCtD
Enalapril—ABCB1—Erlotinib—pancreatic cancer	0.0387	0.0592	CbGbCtD
Enalapril—ABCB1—Irinotecan—pancreatic cancer	0.035	0.0534	CbGbCtD
Enalapril—CYP3A4—Tamoxifen—pancreatic cancer	0.0273	0.0417	CbGbCtD
Enalapril—ABCB1—Docetaxel—pancreatic cancer	0.0256	0.0391	CbGbCtD
Enalapril—ABCB1—Sunitinib—pancreatic cancer	0.0255	0.039	CbGbCtD
Enalapril—CYP3A4—Erlotinib—pancreatic cancer	0.0232	0.0354	CbGbCtD
Enalapril—CYP3A4—Irinotecan—pancreatic cancer	0.021	0.032	CbGbCtD
Enalapril—ABCB1—Doxorubicin—pancreatic cancer	0.0191	0.0292	CbGbCtD
Enalapril—CYP3A4—Docetaxel—pancreatic cancer	0.0154	0.0235	CbGbCtD
Enalapril—CYP3A4—Sunitinib—pancreatic cancer	0.0153	0.0233	CbGbCtD
Enalapril—CYP3A4—Doxorubicin—pancreatic cancer	0.0114	0.0175	CbGbCtD
Enalapril—Captopril—MMP2—pancreatic cancer	0.00519	0.558	CrCbGaD
Enalapril—Captopril—MMP9—pancreatic cancer	0.00341	0.367	CrCbGaD
Enalapril—Nateglinide—PPARG—pancreatic cancer	0.000702	0.0754	CrCbGaD
Enalapril—Abdominal pain—Irinotecan—pancreatic cancer	0.000247	0.000736	CcSEcCtD
Enalapril—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000247	0.000736	CcSEcCtD
Enalapril—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000247	0.000735	CcSEcCtD
Enalapril—Bronchitis—Epirubicin—pancreatic cancer	0.000247	0.000734	CcSEcCtD
Enalapril—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000245	0.000731	CcSEcCtD
Enalapril—Anaemia—Docetaxel—pancreatic cancer	0.000245	0.000729	CcSEcCtD
Enalapril—Pancytopenia—Epirubicin—pancreatic cancer	0.000243	0.000725	CcSEcCtD
Enalapril—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.000242	0.000721	CcSEcCtD
Enalapril—Vomiting—Sunitinib—pancreatic cancer	0.000241	0.000718	CcSEcCtD
Enalapril—Body temperature increased—Gemcitabine—pancreatic cancer	0.000241	0.000717	CcSEcCtD
Enalapril—Neutropenia—Epirubicin—pancreatic cancer	0.00024	0.000714	CcSEcCtD
Enalapril—Dysuria—Epirubicin—pancreatic cancer	0.00024	0.000714	CcSEcCtD
Enalapril—Rash—Sunitinib—pancreatic cancer	0.000239	0.000712	CcSEcCtD
Enalapril—Dermatitis—Sunitinib—pancreatic cancer	0.000239	0.000712	CcSEcCtD
Enalapril—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000238	0.000709	CcSEcCtD
Enalapril—Urticaria—Fluorouracil—pancreatic cancer	0.000238	0.000708	CcSEcCtD
Enalapril—Headache—Sunitinib—pancreatic cancer	0.000238	0.000708	CcSEcCtD
Enalapril—Syncope—Docetaxel—pancreatic cancer	0.000237	0.000707	CcSEcCtD
Enalapril—Influenza—Doxorubicin—pancreatic cancer	0.000237	0.000706	CcSEcCtD
Enalapril—Asthma—Doxorubicin—pancreatic cancer	0.000237	0.000706	CcSEcCtD
Enalapril—Dysphagia—Doxorubicin—pancreatic cancer	0.000237	0.000706	CcSEcCtD
Enalapril—Leukopenia—Docetaxel—pancreatic cancer	0.000237	0.000706	CcSEcCtD
Enalapril—Pollakiuria—Epirubicin—pancreatic cancer	0.000237	0.000705	CcSEcCtD
Enalapril—Body temperature increased—Fluorouracil—pancreatic cancer	0.000237	0.000705	CcSEcCtD
Enalapril—Eosinophilia—Doxorubicin—pancreatic cancer	0.000235	0.000699	CcSEcCtD
Enalapril—Palpitations—Docetaxel—pancreatic cancer	0.000234	0.000697	CcSEcCtD
Enalapril—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000234	0.000697	CcSEcCtD
Enalapril—Loss of consciousness—Docetaxel—pancreatic cancer	0.000233	0.000693	CcSEcCtD
Enalapril—Pancreatitis—Doxorubicin—pancreatic cancer	0.000233	0.000692	CcSEcCtD
Enalapril—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000231	0.000688	CcSEcCtD
Enalapril—Cough—Docetaxel—pancreatic cancer	0.000231	0.000688	CcSEcCtD
Enalapril—Angina pectoris—Doxorubicin—pancreatic cancer	0.000231	0.000688	CcSEcCtD
Enalapril—Hypersensitivity—Irinotecan—pancreatic cancer	0.00023	0.000686	CcSEcCtD
Enalapril—Pneumonia—Epirubicin—pancreatic cancer	0.00023	0.000684	CcSEcCtD
Enalapril—Bronchitis—Doxorubicin—pancreatic cancer	0.000228	0.000679	CcSEcCtD
Enalapril—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000227	0.000675	CcSEcCtD
Enalapril—Myalgia—Docetaxel—pancreatic cancer	0.000225	0.000671	CcSEcCtD
Enalapril—Chest pain—Docetaxel—pancreatic cancer	0.000225	0.000671	CcSEcCtD
Enalapril—Arthralgia—Docetaxel—pancreatic cancer	0.000225	0.000671	CcSEcCtD
Enalapril—Nausea—Sunitinib—pancreatic cancer	0.000225	0.000671	CcSEcCtD
Enalapril—Pancytopenia—Doxorubicin—pancreatic cancer	0.000225	0.000671	CcSEcCtD
Enalapril—Renal failure—Epirubicin—pancreatic cancer	0.000225	0.000669	CcSEcCtD
Enalapril—Asthenia—Irinotecan—pancreatic cancer	0.000224	0.000668	CcSEcCtD
Enalapril—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000224	0.000667	CcSEcCtD
Enalapril—Stomatitis—Epirubicin—pancreatic cancer	0.000223	0.000663	CcSEcCtD
Enalapril—Jaundice—Epirubicin—pancreatic cancer	0.000223	0.000663	CcSEcCtD
Enalapril—Urinary tract infection—Epirubicin—pancreatic cancer	0.000222	0.000661	CcSEcCtD
Enalapril—Conjunctivitis—Epirubicin—pancreatic cancer	0.000222	0.000661	CcSEcCtD
Enalapril—Neutropenia—Doxorubicin—pancreatic cancer	0.000222	0.00066	CcSEcCtD
Enalapril—Dysuria—Doxorubicin—pancreatic cancer	0.000222	0.00066	CcSEcCtD
Enalapril—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000221	0.000657	CcSEcCtD
Enalapril—Dry mouth—Docetaxel—pancreatic cancer	0.00022	0.000656	CcSEcCtD
Enalapril—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.00022	0.000656	CcSEcCtD
Enalapril—Pollakiuria—Doxorubicin—pancreatic cancer	0.000219	0.000652	CcSEcCtD
Enalapril—Asthenia—Gemcitabine—pancreatic cancer	0.000218	0.00065	CcSEcCtD
Enalapril—Confusional state—Docetaxel—pancreatic cancer	0.000218	0.000649	CcSEcCtD
Enalapril—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000216	0.000644	CcSEcCtD
Enalapril—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000216	0.000643	CcSEcCtD
Enalapril—Oedema—Docetaxel—pancreatic cancer	0.000216	0.000643	CcSEcCtD
Enalapril—Epistaxis—Epirubicin—pancreatic cancer	0.000216	0.000642	CcSEcCtD
Enalapril—Pruritus—Gemcitabine—pancreatic cancer	0.000215	0.000641	CcSEcCtD
Enalapril—Sinusitis—Epirubicin—pancreatic cancer	0.000214	0.000638	CcSEcCtD
Enalapril—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000214	0.000637	CcSEcCtD
Enalapril—Diarrhoea—Irinotecan—pancreatic cancer	0.000214	0.000637	CcSEcCtD
Enalapril—Agranulocytosis—Epirubicin—pancreatic cancer	0.000213	0.000635	CcSEcCtD
Enalapril—Pneumonia—Doxorubicin—pancreatic cancer	0.000213	0.000633	CcSEcCtD
Enalapril—Shock—Docetaxel—pancreatic cancer	0.000213	0.000633	CcSEcCtD
Enalapril—Pruritus—Fluorouracil—pancreatic cancer	0.000212	0.000631	CcSEcCtD
Enalapril—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000212	0.00063	CcSEcCtD
Enalapril—Tachycardia—Docetaxel—pancreatic cancer	0.000211	0.000628	CcSEcCtD
Enalapril—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.00021	0.000624	CcSEcCtD
Enalapril—Bradycardia—Epirubicin—pancreatic cancer	0.000209	0.000622	CcSEcCtD
Enalapril—Diarrhoea—Gemcitabine—pancreatic cancer	0.000208	0.00062	CcSEcCtD
Enalapril—Renal failure—Doxorubicin—pancreatic cancer	0.000208	0.000619	CcSEcCtD
Enalapril—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000207	0.000617	CcSEcCtD
Enalapril—Dizziness—Irinotecan—pancreatic cancer	0.000207	0.000615	CcSEcCtD
Enalapril—Jaundice—Doxorubicin—pancreatic cancer	0.000206	0.000614	CcSEcCtD
Enalapril—Stomatitis—Doxorubicin—pancreatic cancer	0.000206	0.000614	CcSEcCtD
Enalapril—Anorexia—Docetaxel—pancreatic cancer	0.000206	0.000613	CcSEcCtD
Enalapril—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000206	0.000612	CcSEcCtD
Enalapril—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000206	0.000612	CcSEcCtD
Enalapril—Hepatitis—Epirubicin—pancreatic cancer	0.000205	0.000611	CcSEcCtD
Enalapril—Diarrhoea—Fluorouracil—pancreatic cancer	0.000205	0.00061	CcSEcCtD
Enalapril—Pharyngitis—Epirubicin—pancreatic cancer	0.000204	0.000606	CcSEcCtD
Enalapril—Hypotension—Docetaxel—pancreatic cancer	0.000202	0.000601	CcSEcCtD
Enalapril—Epistaxis—Doxorubicin—pancreatic cancer	0.000199	0.000594	CcSEcCtD
Enalapril—Vomiting—Irinotecan—pancreatic cancer	0.000199	0.000592	CcSEcCtD
Enalapril—Sinusitis—Doxorubicin—pancreatic cancer	0.000198	0.000591	CcSEcCtD
Enalapril—Dizziness—Fluorouracil—pancreatic cancer	0.000198	0.000589	CcSEcCtD
Enalapril—Visual impairment—Epirubicin—pancreatic cancer	0.000198	0.000589	CcSEcCtD
Enalapril—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000197	0.000588	CcSEcCtD
Enalapril—Rash—Irinotecan—pancreatic cancer	0.000197	0.000587	CcSEcCtD
Enalapril—Dermatitis—Irinotecan—pancreatic cancer	0.000197	0.000586	CcSEcCtD
Enalapril—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000197	0.000586	CcSEcCtD
Enalapril—Headache—Irinotecan—pancreatic cancer	0.000196	0.000583	CcSEcCtD
Enalapril—Insomnia—Docetaxel—pancreatic cancer	0.000195	0.000582	CcSEcCtD
Enalapril—Paraesthesia—Docetaxel—pancreatic cancer	0.000194	0.000578	CcSEcCtD
Enalapril—Erythema multiforme—Epirubicin—pancreatic cancer	0.000194	0.000578	CcSEcCtD
Enalapril—Vomiting—Gemcitabine—pancreatic cancer	0.000194	0.000576	CcSEcCtD
Enalapril—Bradycardia—Doxorubicin—pancreatic cancer	0.000193	0.000575	CcSEcCtD
Enalapril—Dyspnoea—Docetaxel—pancreatic cancer	0.000193	0.000574	CcSEcCtD
Enalapril—Somnolence—Docetaxel—pancreatic cancer	0.000192	0.000572	CcSEcCtD
Enalapril—Rash—Gemcitabine—pancreatic cancer	0.000192	0.000572	CcSEcCtD
Enalapril—Dermatitis—Gemcitabine—pancreatic cancer	0.000192	0.000571	CcSEcCtD
Enalapril—Tinnitus—Epirubicin—pancreatic cancer	0.000191	0.000569	CcSEcCtD
Enalapril—Headache—Gemcitabine—pancreatic cancer	0.000191	0.000568	CcSEcCtD
Enalapril—Flushing—Epirubicin—pancreatic cancer	0.00019	0.000567	CcSEcCtD
Enalapril—Vomiting—Fluorouracil—pancreatic cancer	0.00019	0.000567	CcSEcCtD
Enalapril—Dyspepsia—Docetaxel—pancreatic cancer	0.00019	0.000566	CcSEcCtD
Enalapril—Hepatitis—Doxorubicin—pancreatic cancer	0.00019	0.000565	CcSEcCtD
Enalapril—Rash—Fluorouracil—pancreatic cancer	0.000189	0.000562	CcSEcCtD
Enalapril—Dermatitis—Fluorouracil—pancreatic cancer	0.000189	0.000562	CcSEcCtD
Enalapril—Pharyngitis—Doxorubicin—pancreatic cancer	0.000188	0.000561	CcSEcCtD
Enalapril—Decreased appetite—Docetaxel—pancreatic cancer	0.000188	0.000559	CcSEcCtD
Enalapril—Headache—Fluorouracil—pancreatic cancer	0.000188	0.000558	CcSEcCtD
Enalapril—Fatigue—Docetaxel—pancreatic cancer	0.000186	0.000555	CcSEcCtD
Enalapril—Nausea—Irinotecan—pancreatic cancer	0.000186	0.000553	CcSEcCtD
Enalapril—Constipation—Docetaxel—pancreatic cancer	0.000185	0.00055	CcSEcCtD
Enalapril—Arrhythmia—Epirubicin—pancreatic cancer	0.000183	0.000546	CcSEcCtD
Enalapril—Visual impairment—Doxorubicin—pancreatic cancer	0.000183	0.000545	CcSEcCtD
Enalapril—Alopecia—Epirubicin—pancreatic cancer	0.000181	0.00054	CcSEcCtD
Enalapril—Nausea—Gemcitabine—pancreatic cancer	0.000181	0.000539	CcSEcCtD
Enalapril—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000179	0.000534	CcSEcCtD
Enalapril—Erythema—Epirubicin—pancreatic cancer	0.000179	0.000532	CcSEcCtD
Enalapril—Feeling abnormal—Docetaxel—pancreatic cancer	0.000178	0.00053	CcSEcCtD
Enalapril—Nausea—Fluorouracil—pancreatic cancer	0.000178	0.000529	CcSEcCtD
Enalapril—Tinnitus—Doxorubicin—pancreatic cancer	0.000177	0.000527	CcSEcCtD
Enalapril—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000177	0.000526	CcSEcCtD
Enalapril—Flushing—Doxorubicin—pancreatic cancer	0.000176	0.000525	CcSEcCtD
Enalapril—Flatulence—Epirubicin—pancreatic cancer	0.000176	0.000524	CcSEcCtD
Enalapril—Tension—Epirubicin—pancreatic cancer	0.000175	0.000522	CcSEcCtD
Enalapril—Dysgeusia—Epirubicin—pancreatic cancer	0.000175	0.000521	CcSEcCtD
Enalapril—Nervousness—Epirubicin—pancreatic cancer	0.000173	0.000516	CcSEcCtD
Enalapril—Back pain—Epirubicin—pancreatic cancer	0.000173	0.000514	CcSEcCtD
Enalapril—Muscle spasms—Epirubicin—pancreatic cancer	0.000172	0.000511	CcSEcCtD
Enalapril—Abdominal pain—Docetaxel—pancreatic cancer	0.000171	0.000509	CcSEcCtD
Enalapril—Body temperature increased—Docetaxel—pancreatic cancer	0.000171	0.000509	CcSEcCtD
Enalapril—Arrhythmia—Doxorubicin—pancreatic cancer	0.00017	0.000505	CcSEcCtD
Enalapril—Vision blurred—Epirubicin—pancreatic cancer	0.000168	0.000501	CcSEcCtD
Enalapril—Alopecia—Doxorubicin—pancreatic cancer	0.000168	0.000499	CcSEcCtD
Enalapril—Erythema—Doxorubicin—pancreatic cancer	0.000165	0.000492	CcSEcCtD
Enalapril—Anaemia—Epirubicin—pancreatic cancer	0.000165	0.000491	CcSEcCtD
Enalapril—Agitation—Epirubicin—pancreatic cancer	0.000164	0.000489	CcSEcCtD
Enalapril—Flatulence—Doxorubicin—pancreatic cancer	0.000163	0.000485	CcSEcCtD
Enalapril—Tension—Doxorubicin—pancreatic cancer	0.000162	0.000483	CcSEcCtD
Enalapril—Dysgeusia—Doxorubicin—pancreatic cancer	0.000162	0.000482	CcSEcCtD
Enalapril—Nervousness—Doxorubicin—pancreatic cancer	0.00016	0.000478	CcSEcCtD
Enalapril—Vertigo—Epirubicin—pancreatic cancer	0.00016	0.000478	CcSEcCtD
Enalapril—Syncope—Epirubicin—pancreatic cancer	0.00016	0.000477	CcSEcCtD
Enalapril—Leukopenia—Epirubicin—pancreatic cancer	0.00016	0.000476	CcSEcCtD
Enalapril—Back pain—Doxorubicin—pancreatic cancer	0.00016	0.000476	CcSEcCtD
Enalapril—Hypersensitivity—Docetaxel—pancreatic cancer	0.000159	0.000474	CcSEcCtD
Enalapril—Muscle spasms—Doxorubicin—pancreatic cancer	0.000159	0.000473	CcSEcCtD
Enalapril—Palpitations—Epirubicin—pancreatic cancer	0.000158	0.00047	CcSEcCtD
Enalapril—Loss of consciousness—Epirubicin—pancreatic cancer	0.000157	0.000467	CcSEcCtD
Enalapril—Cough—Epirubicin—pancreatic cancer	0.000156	0.000464	CcSEcCtD
Enalapril—Vision blurred—Doxorubicin—pancreatic cancer	0.000156	0.000464	CcSEcCtD
Enalapril—Asthenia—Docetaxel—pancreatic cancer	0.000155	0.000462	CcSEcCtD
Enalapril—Pruritus—Docetaxel—pancreatic cancer	0.000153	0.000455	CcSEcCtD
Enalapril—Anaemia—Doxorubicin—pancreatic cancer	0.000153	0.000455	CcSEcCtD
Enalapril—Myalgia—Epirubicin—pancreatic cancer	0.000152	0.000453	CcSEcCtD
Enalapril—Arthralgia—Epirubicin—pancreatic cancer	0.000152	0.000453	CcSEcCtD
Enalapril—Chest pain—Epirubicin—pancreatic cancer	0.000152	0.000453	CcSEcCtD
Enalapril—Agitation—Doxorubicin—pancreatic cancer	0.000152	0.000452	CcSEcCtD
Enalapril—Discomfort—Epirubicin—pancreatic cancer	0.00015	0.000447	CcSEcCtD
Enalapril—Dry mouth—Epirubicin—pancreatic cancer	0.000149	0.000443	CcSEcCtD
Enalapril—Vertigo—Doxorubicin—pancreatic cancer	0.000148	0.000442	CcSEcCtD
Enalapril—Syncope—Doxorubicin—pancreatic cancer	0.000148	0.000441	CcSEcCtD
Enalapril—Leukopenia—Doxorubicin—pancreatic cancer	0.000148	0.00044	CcSEcCtD
Enalapril—Diarrhoea—Docetaxel—pancreatic cancer	0.000148	0.00044	CcSEcCtD
Enalapril—Confusional state—Epirubicin—pancreatic cancer	0.000147	0.000438	CcSEcCtD
Enalapril—Palpitations—Doxorubicin—pancreatic cancer	0.000146	0.000435	CcSEcCtD
Enalapril—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000146	0.000434	CcSEcCtD
Enalapril—Oedema—Epirubicin—pancreatic cancer	0.000146	0.000434	CcSEcCtD
Enalapril—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000145	0.000432	CcSEcCtD
Enalapril—Cough—Doxorubicin—pancreatic cancer	0.000144	0.000429	CcSEcCtD
Enalapril—Shock—Epirubicin—pancreatic cancer	0.000143	0.000427	CcSEcCtD
Enalapril—Dizziness—Docetaxel—pancreatic cancer	0.000143	0.000425	CcSEcCtD
Enalapril—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000143	0.000425	CcSEcCtD
Enalapril—Tachycardia—Epirubicin—pancreatic cancer	0.000142	0.000424	CcSEcCtD
Enalapril—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000141	0.00042	CcSEcCtD
Enalapril—Chest pain—Doxorubicin—pancreatic cancer	0.000141	0.000419	CcSEcCtD
Enalapril—Arthralgia—Doxorubicin—pancreatic cancer	0.000141	0.000419	CcSEcCtD
Enalapril—Myalgia—Doxorubicin—pancreatic cancer	0.000141	0.000419	CcSEcCtD
Enalapril—Discomfort—Doxorubicin—pancreatic cancer	0.000139	0.000414	CcSEcCtD
Enalapril—Anorexia—Epirubicin—pancreatic cancer	0.000139	0.000414	CcSEcCtD
Enalapril—Dry mouth—Doxorubicin—pancreatic cancer	0.000138	0.00041	CcSEcCtD
Enalapril—Vomiting—Docetaxel—pancreatic cancer	0.000137	0.000409	CcSEcCtD
Enalapril—Rash—Docetaxel—pancreatic cancer	0.000136	0.000406	CcSEcCtD
Enalapril—Hypotension—Epirubicin—pancreatic cancer	0.000136	0.000405	CcSEcCtD
Enalapril—Dermatitis—Docetaxel—pancreatic cancer	0.000136	0.000405	CcSEcCtD
Enalapril—Confusional state—Doxorubicin—pancreatic cancer	0.000136	0.000405	CcSEcCtD
Enalapril—Headache—Docetaxel—pancreatic cancer	0.000135	0.000403	CcSEcCtD
Enalapril—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000135	0.000402	CcSEcCtD
Enalapril—Oedema—Doxorubicin—pancreatic cancer	0.000135	0.000402	CcSEcCtD
Enalapril—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000133	0.000395	CcSEcCtD
Enalapril—Shock—Doxorubicin—pancreatic cancer	0.000133	0.000395	CcSEcCtD
Enalapril—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000132	0.000393	CcSEcCtD
Enalapril—Insomnia—Epirubicin—pancreatic cancer	0.000132	0.000392	CcSEcCtD
Enalapril—Tachycardia—Doxorubicin—pancreatic cancer	0.000132	0.000392	CcSEcCtD
Enalapril—Paraesthesia—Epirubicin—pancreatic cancer	0.000131	0.00039	CcSEcCtD
Enalapril—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.00013	0.000388	CcSEcCtD
Enalapril—Dyspnoea—Epirubicin—pancreatic cancer	0.00013	0.000387	CcSEcCtD
Enalapril—Somnolence—Epirubicin—pancreatic cancer	0.00013	0.000386	CcSEcCtD
Enalapril—Anorexia—Doxorubicin—pancreatic cancer	0.000129	0.000383	CcSEcCtD
Enalapril—Nausea—Docetaxel—pancreatic cancer	0.000128	0.000382	CcSEcCtD
Enalapril—Dyspepsia—Epirubicin—pancreatic cancer	0.000128	0.000382	CcSEcCtD
Enalapril—Decreased appetite—Epirubicin—pancreatic cancer	0.000127	0.000377	CcSEcCtD
Enalapril—Hypotension—Doxorubicin—pancreatic cancer	0.000126	0.000375	CcSEcCtD
Enalapril—Fatigue—Epirubicin—pancreatic cancer	0.000126	0.000374	CcSEcCtD
Enalapril—Constipation—Epirubicin—pancreatic cancer	0.000125	0.000371	CcSEcCtD
Enalapril—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000123	0.000366	CcSEcCtD
Enalapril—Insomnia—Doxorubicin—pancreatic cancer	0.000122	0.000363	CcSEcCtD
Enalapril—Paraesthesia—Doxorubicin—pancreatic cancer	0.000121	0.000361	CcSEcCtD
Enalapril—Dyspnoea—Doxorubicin—pancreatic cancer	0.00012	0.000358	CcSEcCtD
Enalapril—Feeling abnormal—Epirubicin—pancreatic cancer	0.00012	0.000358	CcSEcCtD
Enalapril—Somnolence—Doxorubicin—pancreatic cancer	0.00012	0.000357	CcSEcCtD
Enalapril—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000119	0.000355	CcSEcCtD
Enalapril—Dyspepsia—Doxorubicin—pancreatic cancer	0.000119	0.000353	CcSEcCtD
Enalapril—Decreased appetite—Doxorubicin—pancreatic cancer	0.000117	0.000349	CcSEcCtD
Enalapril—Fatigue—Doxorubicin—pancreatic cancer	0.000116	0.000346	CcSEcCtD
Enalapril—Urticaria—Epirubicin—pancreatic cancer	0.000116	0.000345	CcSEcCtD
Enalapril—Constipation—Doxorubicin—pancreatic cancer	0.000115	0.000343	CcSEcCtD
Enalapril—Abdominal pain—Epirubicin—pancreatic cancer	0.000115	0.000343	CcSEcCtD
Enalapril—Body temperature increased—Epirubicin—pancreatic cancer	0.000115	0.000343	CcSEcCtD
Enalapril—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000111	0.000331	CcSEcCtD
Enalapril—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.00011	0.000328	CcSEcCtD
Enalapril—Hypersensitivity—Epirubicin—pancreatic cancer	0.000107	0.00032	CcSEcCtD
Enalapril—Urticaria—Doxorubicin—pancreatic cancer	0.000107	0.000319	CcSEcCtD
Enalapril—Body temperature increased—Doxorubicin—pancreatic cancer	0.000107	0.000317	CcSEcCtD
Enalapril—Abdominal pain—Doxorubicin—pancreatic cancer	0.000107	0.000317	CcSEcCtD
Enalapril—Asthenia—Epirubicin—pancreatic cancer	0.000105	0.000311	CcSEcCtD
Enalapril—Pruritus—Epirubicin—pancreatic cancer	0.000103	0.000307	CcSEcCtD
Enalapril—Diarrhoea—Epirubicin—pancreatic cancer	9.97e-05	0.000297	CcSEcCtD
Enalapril—Hypersensitivity—Doxorubicin—pancreatic cancer	9.94e-05	0.000296	CcSEcCtD
Enalapril—Asthenia—Doxorubicin—pancreatic cancer	9.68e-05	0.000288	CcSEcCtD
Enalapril—Dizziness—Epirubicin—pancreatic cancer	9.64e-05	0.000287	CcSEcCtD
Enalapril—Pruritus—Doxorubicin—pancreatic cancer	9.54e-05	0.000284	CcSEcCtD
Enalapril—Vomiting—Epirubicin—pancreatic cancer	9.27e-05	0.000276	CcSEcCtD
Enalapril—Diarrhoea—Doxorubicin—pancreatic cancer	9.23e-05	0.000275	CcSEcCtD
Enalapril—Rash—Epirubicin—pancreatic cancer	9.19e-05	0.000274	CcSEcCtD
Enalapril—Dermatitis—Epirubicin—pancreatic cancer	9.18e-05	0.000273	CcSEcCtD
Enalapril—Headache—Epirubicin—pancreatic cancer	9.13e-05	0.000272	CcSEcCtD
Enalapril—Dizziness—Doxorubicin—pancreatic cancer	8.92e-05	0.000266	CcSEcCtD
Enalapril—Nausea—Epirubicin—pancreatic cancer	8.66e-05	0.000258	CcSEcCtD
Enalapril—Vomiting—Doxorubicin—pancreatic cancer	8.57e-05	0.000255	CcSEcCtD
Enalapril—Rash—Doxorubicin—pancreatic cancer	8.5e-05	0.000253	CcSEcCtD
Enalapril—Dermatitis—Doxorubicin—pancreatic cancer	8.5e-05	0.000253	CcSEcCtD
Enalapril—Headache—Doxorubicin—pancreatic cancer	8.45e-05	0.000252	CcSEcCtD
Enalapril—Nausea—Doxorubicin—pancreatic cancer	8.01e-05	0.000238	CcSEcCtD
